Serious rash with lamotrigine after carbamazepine discontinuation: a case report.
Subuh Surja
Anton A
AA
Brotzge
Kathryn E
KE
El-Mallakh
Rif S
RS
D000927:Anticonvulsants / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002220:Carbamazepine / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000378:metabolism; D014227:Triazines / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use
D000927:Anticonvulsants; D014227:Triazines; D002220:Carbamazepine; D003577:Cytochrome P-450 Enzyme System; D000077213:Lamotrigine